![](/img/cover-not-exists.png)
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
Manegold, C., van Zandwijk, N., Szczesna, A., Zatloukal, P., Au, J. S. K., Blasinska-Morawiec, M., Serwatowski, P., Krzakowski, M., Jassem, J., Tan, E. H., Benner, R. J., Ingrosso, A., Meech, S. J., RVolume:
23
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdr030
Date:
January, 2012
File:
PDF, 268 KB
english, 2012